Page 3 - Best Immunotherapy with Keytruda (Pembolizumab) Immunotherapy with Keytruda (Pembolizumab): TOP 68 doctors

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Associate Professor Muhammed Mustafa Atci specializes in medical oncology at İstinye University Liv Hospital Topkapı, with a strong focus on immunotherapy treatments.

• Member of the American Society of Clinical Oncology (ASCO)
• Published multiple peer-reviewed articles on cancer treatment outcomes
• Education Coordinator for Medical Oncology Sub-Branch
• Extensive experience in treating various cancer types with immunotherapy

Assoc. Prof. Ayse Irem Yasin specializes in immunotherapy for various cancers at Medipol Acibadem District Hospital, with expertise in Keytruda treatments.

• ESMO Board Certified – recognized for high standards in oncology
• Fellowship-trained in Medical Oncology at Bezmialem Vakif University
• Experienced in treating lung, breast, and gastrointestinal cancers
• International observerships in Italy and the US enhance her practice

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Professor Bosch leads global research in Chronic Lymphocytic Leukemia (CLL) and lymphoma treatments, with over 80 active clinical trials.

• Specializes in lymphomas and CLL at Hospital Quiron Barcelona
• Published 100+ articles in top journals like NEJM and Nature Medicine
• Head of Hematology at Vall d'Hebron University Hospital
• Develops new therapeutic approaches for lymphoproliferative disorders

Israel's leading specialist in lung cancer immunotherapy – Prof. Peled heads the Thoracic Cancer Unit at Davidoff Cancer Center.

• Expert in Internal Medicine, Pulmonology and Medical Oncology
• Recipient of the ASCO MERIT award for outstanding research
• Head of Research and Detection Unit for Thoracic malignancies at Sheba Medical Center
• Chair of IASLC's Early Detection & Prevention Committee

Deputy Head of the Department of Oncology at Rambam Medical Center – Dr. Bar-Sela specializes in cutting-edge cancer treatments.

• Expert in immunotherapy with Keytruda (pembrolizumab)
• Focused on personalized cancer treatment plans
• Works at a leading oncology department in Israel

Chief Physician of the Oncology Center at Assuta Medical Center, specializing in immunotherapy treatments.

• Oncologist with extensive experience in targeted therapies
• Leads a dedicated team for advanced cancer treatments
• Focuses on personalized treatment plans for patients

Prof. Dr. Serdar Bedii Omay has over 65 scientific articles in hematology and bone marrow transplantation, with extensive international research experience.

• Specialized in hematology with a PhD from Japan's Mie Medical School
• Professor at Ege University and Karadeniz Technical University
• Over 34 conference presentations in the field

Prof. Baytan specializes in childhood cancers and hematology, with extensive experience in leukemia and lymphoma treatments.

• Graduated from Ankara University Medical Faculty
• Published 15 articles in international journals
• Specializes in iron deficiency and vitamin deficiency treatments
• Works at Emsey Hospital

Prof. Osman Ilhan pioneered Turkey's first bone marrow stem cell transplant and trained at MD Anderson Cancer Center. Now leading at Koru Ankara Hospital, he brings 48 years of experience of hematology expertise.

• Specializes in immunotherapy and stem cell therapies for blood cancers
• Founding president of the Cellular Therapy and Regenerative Medicine Association
• Holder of four medical patents including cancer stem cell research
• Platinum CME-certified by the European Hematology Association
• 300+ PubMed publications with over 5,000 citations

Dr. Ahmer Arif Shaikh specializes in oral cancer treatment and functional rehabilitation at HCG Manavata Cancer Centre.

• 15 years of experience of experience in Surgical Oncology
• Expert in oral cancer, organ preservation, and functional rehabilitation
• Proficient in major maxillofacial and head & neck surgeries
• Fellowship training in Head & Neck Surgical Oncology
• Active researcher with multiple publications

Dr. Prakash Pandit specializes in advanced radiation oncology techniques at HCG Manavata Cancer Centre, focusing on precise cancer treatments.

• MD in Radiation Oncology with expertise in Tomotherapy-H
• Uses Linear Accelerator & Brachytherapy for targeted therapy
• Consultant with a focus on innovative cancer treatments

30 years of experience of surgical oncology experience – Dr. Nagarkar has performed over 50,000 cancer surgeries at HCG Manavata Cancer Centre.

• Trained at Tata Memorial Hospital – India's premier cancer center
• Specializes in breast and thoracic surgical oncology
• Involved in 200+ clinical trials for new cancer treatments
• Professor for surgical oncology at Delhi National Board

Dr. Shaunak presented research on stomach cancer at the American Society of Clinical Oncology symposium – a rare honor for young oncologists.

• Specializes in molecular-based cancer treatments and targeted therapies
• DNB-trained in Medical Oncology from Indraprastha Apollo Hospital
• Lectured at International Winter School of Oncology at AIIMS
• Former Registrar at Jawaharlal Nehru Cancer Hospital

Dr. Lalit has performed over 10,000 major surgeries, specializing in gastrointestinal cancer and minimally invasive techniques.

• 15 years of experience of surgical experience with excellent outcomes
• Fellowship-trained at Tata Medical Centre, a leader in oncology
• Co-principal investigator in multiple cancer research studies
• Special focus on gastrointestinal cancers
• Published in national and international journals